Obesity
Latest News
Obesity
The basics of BMI
BMI, or Body Mass Index, is a standard way to assess weight status - learn why and where it came from
2024-08-22T13:50:00Z
Obesity
A primer on GLP-1 receptor agonists for weight loss
An overview on select GLP-1 receptor agonist treatments that help promote blood sugar management and weight loss
2024-07-31T18:30:00Z
Advances in treatment
GLP-1 agonists have been highly publicized for their ability to help patients seeking to lose weight. While research continues to advance this class of drugs, other new approaches for weight management are being studied by clinical researchers. For example, small interfering RNA (siRNA) therapeutics are a cutting-edge approach being explored to target obesity genetically. By targeting what is called the 'RNA interference pathway' these treatments aim to shut down specific genes involved in obesity related disease development.
You can get involved
With each passing year the medical community obtains a greater understanding of factors related to weight gain and risk for obesity and related disease development. Clinical research studies play an important role in ultimately bringing new therapies to market and also identifying effective combinations of diet, exercise and medicines capable of transforming patient lives. Want to explore research opportunities? Take a look at trials that may be recruiting near you!
RECRUITING TRIALS
References
- National Heart, Lung and Blood Institute: What are overweight and obesity? Updated March 24, 2022
- Mayo Clinic: Obesity: Symptoms and Causes. Updated July 22, 2023
- Cleveland Clinic: GLP-1 Agonists Updated July 25, 2023